Big news broke on Day Two of the Health Information Technologies: Harnessing Wireless Innovation hearings held by the Subcommittee on Communications and Technology. The FDA has publicly announced its policy on mobile medical apps.
The FDA's decision not to regulate the sale or general use of smartphones and tablets is viewed as a huge breakthrough for innovators in the mobile healthcare space. Mobile platform developers will no longer have to worry about the FDA regulating their processes.
You can find more information on these developments at the U.S. House of Representatives' Energy and Commerce Committee website.
Comments